Skip to main content

Table 2 Comparisons of Pulmonary Function Tests, Symptoms and Drug Nonadherence in the FP and the BDP Groups After First, Second, and Third Months of Treatment

From: Comparison of Effectiveness between Beclomethasone Dipropionate and Fluticasone Propionate in Treatment of Children with Moderate Asthma

Parameters

Flu Mean (SD)

BDP Mean (SD)

P Value

FEV1

   

   First

87.36(11.12)

79.84 (7.79)

0.008

   Second

91.52 (12.67)

82.60 (8.76)

0.006

   Third

90.32 (7.33)

84.84 (7.14)

0.001

FVC

   

   First

82.52 (8.13)

77.80 (8.08)

0.045

   Second

89.36 (9.53)

79.56 (7.64)

0.001

   Third

90 (10.64)

82.86 (5.88)

0.004

FEV1/FVC

   

   First

0.80 (0.046)%

0.79 (0.032)%

0.24

   Second

0.85 (0.033)%

0.82 (0.017)%

0.001

   Third

0.88 (0.029)%

0.83 (0.025)%

0.001

FEF25-75

   

   First

59.20 (6.38)

54.72 (5.79)

0.012

   Second

66.96 (4.81)

62.36 (4.81)

0.003

   Third

73.6 (2.53)

70.0 (4.25)

0.001

Night symptoms

   

   First

3.0 (1.08)

4.44 (0.92)

0.001

   Second

2.12 (0.93)

3.28 (0.68)

0.001

   Third

1.16 (0.85)

2.52 (0.51)

0.001

Daily symptoms

   

   First

1.16 (0.89)

1.68 (1.07)

0.065

   Second

0.40 (0.50)

1.28 (0.94)

0.001

   Third

0.20 (0.41)

0.48 (0.51)

0.039

Drug nonadherence

   

   First

0.72 (0.79)

1.48 (1.22)

0.023

   Second

0.36 (0.63)

0.96 (0.84)

0.003

   Third

0.4 (0.57)

0.64 (0.63)

0.156